GR1002702B - (-)-(3r)-3-μεθυλο-4- {4-[4-(4-πυριδυλο) πιπεραζινο-1-υλο]φαινοξυ} βουτυρικο οξυ. - Google Patents

(-)-(3r)-3-μεθυλο-4- {4-[4-(4-πυριδυλο) πιπεραζινο-1-υλο]φαινοξυ} βουτυρικο οξυ.

Info

Publication number
GR1002702B
GR1002702B GR960100176A GR960100176A GR1002702B GR 1002702 B GR1002702 B GR 1002702B GR 960100176 A GR960100176 A GR 960100176A GR 960100176 A GR960100176 A GR 960100176A GR 1002702 B GR1002702 B GR 1002702B
Authority
GR
Greece
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
GR960100176A
Other languages
Greek (el)
English (en)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of GR1002702B publication Critical patent/GR1002702B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR960100176A 1995-06-01 1996-05-28 (-)-(3r)-3-μεθυλο-4- {4-[4-(4-πυριδυλο) πιπεραζινο-1-υλο]φαινοξυ} βουτυρικο οξυ. GR1002702B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
GR1002702B true GR1002702B (el) 1997-05-22

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960100176A GR1002702B (el) 1995-06-01 1996-05-28 (-)-(3r)-3-μεθυλο-4- {4-[4-(4-πυριδυλο) πιπεραζινο-1-υλο]φαινοξυ} βουτυρικο οξυ.

Country Status (31)

Country Link
EP (1) EP0796247A1 (fr)
JP (1) JP2885941B2 (fr)
KR (1) KR100245957B1 (fr)
AT (1) AT406675B (fr)
AU (1) AU710105B2 (fr)
BE (1) BE1009520A5 (fr)
BR (1) BR9606409A (fr)
CA (1) CA2194397A1 (fr)
CH (1) CH691808A5 (fr)
CZ (1) CZ26997A3 (fr)
DE (1) DE19680509T1 (fr)
DK (1) DK10697A (fr)
ES (1) ES2137886B1 (fr)
FI (1) FI970393A0 (fr)
GB (1) GB2304340B (fr)
GR (1) GR1002702B (fr)
HU (1) HUP9700274A3 (fr)
IE (1) IE960405A1 (fr)
IL (1) IL118477A0 (fr)
IT (1) IT1290839B1 (fr)
LU (1) LU90008B1 (fr)
MC (1) MC2418A1 (fr)
MX (1) MX9700379A (fr)
NL (1) NL1003243C2 (fr)
NO (1) NO307460B1 (fr)
NZ (1) NZ308597A (fr)
PL (1) PL318440A1 (fr)
SE (1) SE510812C2 (fr)
SK (1) SK13097A3 (fr)
TR (1) TR199700020T1 (fr)
WO (1) WO1996038416A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022835A2 (fr) * 1993-03-29 1994-10-13 Zeneca Limited Composes heterocycliques en tant qu'inhibiteurs de l'agregation plaquettaire
WO1994022834A1 (fr) * 1993-03-29 1994-10-13 Zeneca Limited Derives heterocycliques utilises comme inhibiteurs d'agregation plaquettaire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (fr) * 1982-07-28 1985-03-27 The Upjohn Company Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022835A2 (fr) * 1993-03-29 1994-10-13 Zeneca Limited Composes heterocycliques en tant qu'inhibiteurs de l'agregation plaquettaire
WO1994022834A1 (fr) * 1993-03-29 1994-10-13 Zeneca Limited Derives heterocycliques utilises comme inhibiteurs d'agregation plaquettaire

Also Published As

Publication number Publication date
NO970437D0 (no) 1997-01-31
HUP9700274A2 (hu) 1999-06-28
JP2885941B2 (ja) 1999-04-26
FI970393L (fi) 1997-01-30
SE9700203L (sv) 1997-01-24
IL118477A0 (en) 1996-09-12
ITMI961113A0 (it) 1996-05-31
NL1003243C2 (nl) 1996-12-04
NZ308597A (en) 1998-11-25
JPH09512836A (ja) 1997-12-22
AT406675B (de) 2000-07-25
EP0796247A1 (fr) 1997-09-24
CH691808A5 (de) 2001-10-31
TR199700020T1 (tr) 1997-04-22
MC2418A1 (fr) 1997-05-23
GB2304340A (en) 1997-03-19
GB9627127D0 (en) 1997-02-19
ES2137886B1 (es) 2000-08-16
ES2137886A1 (es) 1999-12-16
HU9700274D0 (en) 1997-04-28
CZ26997A3 (en) 1997-08-13
SE9700203D0 (sv) 1997-01-24
BR9606409A (pt) 1997-09-30
SE510812C2 (sv) 1999-06-28
BE1009520A5 (fr) 1997-04-01
NO307460B1 (no) 2000-04-10
MX9700379A (es) 1997-04-30
FI970393A7 (fi) 1997-01-30
IT1290839B1 (it) 1998-12-14
ITMI961113A1 (it) 1997-12-01
AU5827296A (en) 1996-12-18
FI970393A0 (fi) 1997-01-30
LU90008B1 (fr) 1997-04-16
KR100245957B1 (ko) 2000-04-01
IE960405A1 (en) 1996-12-11
ATA900596A (de) 1999-12-15
DK10697A (da) 1997-04-01
GB2304340B (en) 1998-07-29
SK13097A3 (en) 1997-08-06
KR970704689A (ko) 1997-09-06
CA2194397A1 (fr) 1996-12-05
DE19680509T1 (de) 1997-12-04
NO970437L (no) 1997-02-20
PL318440A1 (en) 1997-06-09
AU710105B2 (en) 1999-09-16
HUP9700274A3 (en) 2000-02-28
WO1996038416A1 (fr) 1996-12-05

Similar Documents

Publication Publication Date Title
UA39093C2 (uk) Похідні пептидів, що є інгібіторами еластази лейкоцитів людини, спосіб їх отримання та фармацевтична композиція
IL114449A0 (en) Multiple unit tableted dosage form
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
CA2047744A1 (fr) Methode de synthese de l'huperzine a et de ses analogues et composes utilises pour ce faire
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
GR1002702B (el) (-)-(3r)-3-μεθυλο-4- {4-[4-(4-πυριδυλο) πιπεραζινο-1-υλο]φαινοξυ} βουτυρικο οξυ.
CA2136841A1 (fr) Nouveaux piperidylamides, sulfonamides et sulfoxamides utilisees comme inhibiteurs de la biosynthese du cholesterol
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
AU6482586A (en) ((((3-pyridinyl)methylen)amino)oxy)alkanoic acids
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
BG102405A (en) Pharmaceutical compositions containing thrombocyte aggregation inhibitors
RU95102147A (ru) Производные 1-[2-(1н-инден-3-ил)этил]-4-(нафт-1-ил)пиперазина, способ их получения и содержащие их медикамент и фармацевтический состав
ES8403855A1 (es) "procedimiento para la preparacion de 1-(2,4-diclorofenoxi)-3-(3,4-dimetoxi-b-fenetilamino)-propanol-(2) racemico y opticamente activo".
FR2734818B1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees